Cargando…

Chemical characterization of non‐psychoactive Cannabis sativa L. extracts, in vitro antiproliferative activity and induction of apoptosis in chronic myelogenous leukaemia cancer cells

In this study, extracts from non‐psychoactive Cannabis sativa L. varieties were characterized by means of ultra high‐performance liquid chromatography coupled with high‐resolution mass spectrometry (UHPLC‐HRMS) and their antiproliferative activity was assessed in vitro. The human chronic myelogenous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anceschi, Lisa, Codeluppi, Alessandro, Brighenti, Virginia, Tassinari, Riccardo, Taglioli, Valentina, Marchetti, Lucia, Roncati, Luca, Alessandrini, Andrea, Corsi, Lorenzo, Pellati, Federica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304126/ https://www.ncbi.nlm.nih.gov/pubmed/35107862 http://dx.doi.org/10.1002/ptr.7357

Ejemplares similares

Antiseizure Effects of Fully Characterized Non-Psychoactive Cannabis sativa L. Extracts in the Repeated 6-Hz Corneal Stimulation Test
por: Costa, Anna-Maria, et al.
Publicado: (2021)

Use of (13)C-qNMR Spectroscopy for the Analysis of Non-Psychoactive Cannabinoids in Fibre-Type Cannabis sativa L. (Hemp)
por: Marchetti, Lucia, et al.
Publicado: (2019)

New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp)
por: Pellati, Federica, et al.
Publicado: (2018)

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
por: Pellati, Federica, et al.
Publicado: (2018)

Chemical Characterization and Evaluation of the Antibacterial Activity of Essential Oils from Fibre-Type Cannabis sativa L. (Hemp)
por: Iseppi, Ramona, et al.
Publicado: (2019)

Myelogenic Leukaemia
Publicado: (1915)

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Myelogenous Leukæmia and Its Treatment
por: Debove,
Publicado: (1910)

Micronized / ultramicronized palmitoylethanolamide (PEA) as natural neuroprotector against COVID-19 inflammation
por: Roncati, Luca, et al.
Publicado: (2021)

Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
por: Harris, R., et al.
Publicado: (1978)

Identification of Psychoactive Metabolites from Cannabis sativa, Its Smoke, and Other Phytocannabinoids Using Machine Learning and Multivariate Methods
por: Jagannathan, Ramesh
Publicado: (2020)

Factors influencing prognosis in adults with acute myelogenous leukaemia.
por: Crowther, D., et al.
Publicado: (1975)

Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
por: Cocks, P., et al.
Publicado: (1977)

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
por: Zuhrie, S. R., et al.
Publicado: (1980)

Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia.
por: Smith, B. J., et al.
Publicado: (1976)

A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia
por: Hu, C. W., et al.
Publicado: (2019)

Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest
por: Bruni, Renato, et al.
Publicado: (2019)

Effects of "Cannabis Sativa."
por: Gardner, E. B.
Publicado: (1866)

Disclosing the Antioxidant and Neuroprotective Activity of an Anthocyanin-Rich Extract from Sweet Cherry (Prunus avium L.) Using In Vitro and In Vivo Models
por: Filaferro, Monica, et al.
Publicado: (2022)

Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia
por: Cowan-Jacob, Sandra W., et al.
Publicado: (2006)

Cytogenetic analysis of leukaemic colonies from acute and chronic myelogenous leukaemia.
por: Trent, J. M., et al.
Publicado: (1983)

In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia.
por: Marie, J. P., et al.
Publicado: (1988)

Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
por: Potter, C. G., et al.
Publicado: (1980)

Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia
por: Dalley, C D, et al.
Publicado: (2001)

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia
por: Lee, C-Y, et al.
Publicado: (2007)

Early central nervous system involvement in adults with acute non-myelogenous leukaemia.
por: Lister, T. A., et al.
Publicado: (1977)

Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India
por: Anand, Maninder Singh, et al.
Publicado: (2012)

OGG1 rs1052133 Polymorphism and Genetic Susceptibility to Chronic Myelogenous Leukaemia
por: Hassan, Fathelrahman M
Publicado: (2019)

Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor
por: Corrado, Chiara, et al.
Publicado: (2016)

The Effect of Polyphenols on Pomegranate Fruit Susceptibility to Pilidiella granati Provides Insights into Disease Tolerance Mechanisms
por: Mincuzzi, Annamaria, et al.
Publicado: (2020)

Cannabis Legalization in Canada: Reflections on Public Health and the Governance of Legal Psychoactive Substances
por: Crépault, Jean-François
Publicado: (2018)

Introduction to emerging industrial applications of cannabis (Cannabis sativa L.)
por: Sorrentino, Giuseppe
Publicado: (2021)

Research Progress on Cannabinoids in Cannabis (Cannabis sativa L.) in China
por: Sun, Xiangping
Publicado: (2023)

Growth inhibitory effects of interferon on blast cells from patients with acute myelogenous leukaemia.
por: Rohatiner, A. Z.
Publicado: (1984)

Inorganic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myelogenous Leukaemia
por: Ghosn, Youssef, et al.
Publicado: (2019)

The draft genome and transcriptome of Cannabis sativa
por: van Bakel, Harm, et al.
Publicado: (2011)

Polyploidization for the Genetic Improvement of Cannabis sativa
por: Parsons, Jessica L., et al.
Publicado: (2019)

Terpene synthases from Cannabis sativa
por: Booth, Judith K., et al.
Publicado: (2017)

The complete mitochondrial genome for Cannabis sativa
por: White, Kristin H., et al.
Publicado: (2016)

The antimicrobial effect behind Cannabis sativa
por: Schofs, Laureano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o0tkbjl2jemptl3dntfotar26u